<DOC>
	<DOCNO>NCT01309763</DOCNO>
	<brief_summary>This randomize , control , parallel group , patient-blinded , single-center , phase I pilot study assess tolerability safety repeat subcutaneous administration single-dose AFFITOPE AD03 apply without adjuvant patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Safety Tolerability AFFITOPE AD03</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable Alzheimer 's disease base NINCDS/ADRDA criterion . Assessing severity AD Mini Mental State Examination ( MMSE ) . AD mild degree confirm MMSE score range 20 26 . Hachinski Ischemia Scale use try distinguish AD multiinfarct dementia . A score ≤ 4 suggest AD . The result Magnetic Resonance Imaging scan ( MRI ) patient 's brain consistent diagnosis AD Written inform consent sign dated patient caregiver . The patient 's capability give inform consent confirm independent psychiatrist neurologist . Age 50 80 year . Availability partner/caregiver know patient able accompany patient visit available telephone interview . This necessary neuropsychiatric test require information person know patient well . In addition , increase safety study participant . Adequate visual auditory acuity allow neuropsychological testing . Female patient childbearing potential eligible use medically accept contraceptive method . Availability APOE status A potential participant receive conventional AD hypothyroidism therapy must stable dos least 3 month prior Visit 1 entire trial period . A potential participant stable dos medication he/she take consist illness accord medical history ( except AD hypothyroidism therapy record separately ) least 30 day prior Visit 1 , consider relevant investigator . Pregnant woman . Sexually active woman childbearing potential use medically accept birth control method . Participation another clinical trial within 3 month Visit 1 . History questionable compliance visit schedule ; patient expect complete clinical trial . Presence history allergy component vaccine , consider relevant investigator . Contraindication MRI image metallic endoprosthesis stent implantation last 6 month allergy MRI contrast agent . Operation ( general anaesthesia ) within 3 month prior study entry schedule elective operation whole study period . History and/or presence autoimmune disease , consider relevant investigator . Recent ( ≤3 year since last specific treatment ) history cancer ( Exceptions : basal cell carcinoma , intraepithelial cervical neoplasia ) . Active infectious disease ( e.g. , Hepatitis B , C ) . Presence and/or history Immunodeficiency ( e.g. , HIV infection ) . Significant systemic illness ( e.g. , chronic renal failure , chronic liver disease , poorly control diabetes , poorly control congestive heart failure , deficiency ) , consider relevant investigator . Hypothyroidism , define significant thyroidstimulating hormone elevation . Patients correct hypothyroidism eligible study provide treatment stable 3 month study entry . History significant psychiatric illness schizophrenia , bipolar affective disorder psychotic depression . Current depressive episode ( Geriatric Depression Score ( GDS ) &gt; 5 visit 1 ) Metabolic toxic encephalopathy dementia due general medical condition . Alcoholism substance abuse within past year ( alcohol drug intoxication ) . Wernicke 's encephalopathy History evidence CNS disorder could interpret cause dementia ( infectious inflammatory/demyelinating CNS condition , Creutzfeldt Jacob disease , Parkinson 's disease , Huntington 's disease , brain tumor , subdural haematoma , etc . ) History evidence cerebrovascular disease ( stroke , transient ischemic attack , hemorrhage ) , diagnosis possible , probable definite vascular dementia accordance NINDSAIREN criterion . Epilepsy Prior and/or current treatment experimental immunotherapeutics include IVIG vaccine AD . Prior and/or current treatment immunosuppressive drug . Change dose standard treatment AD hypothyroidism within 3 month prior visit 1 . Change dose previous current medication patient take consist illness accord medical history ( except AD hypothyroidism therapy , AD therapy record separately ) within last 30 day prior visit 1 , clinically relevant .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>